MCHP CFO Disposes 7,356 Shares Under Preplanned 10b5-1 Trading Plan

Rhea-AI Filing Summary

Microchip Technology Inc. insider James Eric Bjornholt, Senior VP and CFO, reported sales of common stock on 08/25/2025 executed under a Rule 10b5-1 trading plan. The filings show two dispositions: 3,053 shares sold at $69.14 and 4,303 shares sold at $68.42.

After these transactions the reporting person beneficially owns 34,313 and 30,010 shares in the two reported lines, held indirectly through a trust. The Form 4 notes the trading plan was adopted on May 23, 2025.

Positive

• Transactions executed under a Rule 10b5-1 plan, signaling pre-planned, rule-compliant insider sales.
• Clear disclosure of share counts and prices for each sale, improving transparency.
• Post-transaction beneficial ownership remains substantial (34,313 and 30,010 shares reported), indicating continued vested interest.

Negative

• Total shares sold: 7,356 (3,053 at $69.14 and 4,303 at $68.42), which reduces the reporting person’s indirect holdings.
• Sales by a senior executive (CFO) may attract investor attention even if planned, potentially raising short-term perception concerns.

Insights

Financial Analyst

TL;DR: Insider sales under a pre-established 10b5-1 plan reduced indirect holdings modestly; transaction appears routine, not event-driven.

The Form 4 documents two non-derivative dispositions totaling 7,356 shares executed on 08/25/2025 under a Rule 10b5-1 plan adopted May 23, 2025. Prices were $69.14 and $68.42, indicating sales near each other in price and suggesting systematic plan execution rather than opportunistic trades. Reported post-transaction beneficial ownership remains in the tens of thousands of shares, held indirectly via a trust, which limits immediate governance implications. For investors, this is a routine liquidity event by a senior officer rather than a signal of company fundamentals.

Corporate Governance Expert

TL;DR: Use of a documented 10b5-1 plan demonstrates procedural compliance and reduces insider-trading concern.

The reporting shows the CFO followed an established Rule 10b5-1 plan for these sales, with the plan adoption date disclosed. Sales were executed by an attorney-in-fact as indicated by the signature block, and shares remain held indirectly in a trust. From a governance perspective, disclosure of the plan and the mechanics of the sale align with best practices for predictable insider transactions and mitigate governance risk related to timing or information asymmetry.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bjornholt James Eric

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SENIOR VP AND CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		S(1)		3,053	D	$69.14	34,313	I	Shares held Indirectly, by Trust.
Common Stock	08/25/2025		S(1)		4,303	D	$68.42	30,010	I	Shares held Indirectly, by Trust.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2025.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Microchip (MCHP) insider James Eric Bjornholt sell?

He sold a total of 7,356 shares of Microchip common stock in two transactions: 3,053 shares at $69.14 and 4,303 shares at $68.42 on 08/25/2025.

Were these insider sales part of a prearranged plan for MCHP?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2025.

How many shares does the reporting person own after the transactions?

The filing reports beneficial ownership of 34,313 and 30,010 shares on the two reported lines, held indirectly through a trust.

What is the reporting person’s role at Microchip?

The reporting person is listed as Senior VP and CFO of Microchip Technology Inc.

Who signed the Form 4 on behalf of the reporting person?

The Form 4 is signed by Deborah L. Wussler, as Attorney-in-Fact on 08/27/2025.